Researchers from the Mitochondrial Medicine Frontier Program at Children's Hospital of Philadelphia (CHOP) have found that developmental delays associated with Leigh syndrome, the most common ...

SAN FRANCISCO--(BUSINESS WIRE)--AllStripes (formerly RDMD), a healthcare technology company dedicated to accelerating research for patients with rare diseases, today announced a multiyear ...

A new study reports that daily use of cannabidiol (CBD) extends lifespan and improves symptoms of Leigh syndrome in both mice and human cellular models. The corresponding study was published in Nature ...

The Cure Mito Foundation, a parent-led organization dedicated to advancing research and treatments for Leigh syndrome, has launched the first-of-its-kind online resource about Leigh syndrome, the most ...

SUMTER COUNTY, S.C. — A Sumter couple is raising awareness about a neurological disorder after a tough diagnosis. Eight-month-old Salem Marra has been diagnosed with Leigh Syndrome. "It causes ...

The effort to raise nearly $2 million to fund a cure for SURF1 Leigh Syndrome, a rare disorder afflicting Indiana’s Zander Marshall, continues with a golf event in September. The second Hope for ...

INDIANA, Pa. (KDKA) - It's been about a year since we told you about Zander Marshall, the little boy from Indiana County fighting Leigh Syndrome - a rare disorder that affects the nervous system.

Researchers have found that developmental delays associated with Leigh syndrome, the most common pediatric mitochondrial disorder, may occur earlier than previously recognized -- even before metabolic ...

Microglia, a type of central nervous system cell, is primarily responsible for neuronal death in Leigh Syndrome and the neurological symptoms related to this mitochondrial disease, according to a new ...

United States Data Bridge Market Research conducted an extensive qualitative study focusing on the “Leigh Syndrome Treatment Market“. Market research reports play a pivotal role in guiding businesses ...

DALLAS--(BUSINESS WIRE)--Taysha Gene Therapies, Inc., (NASDAQ: TSHA), a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of ...